Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Stay updated about 2017

Back for an 8th year, eyeforpharma’s Oncology Market Access & Pricing Summit brings together all stakeholders, including pharma, insurance companies, patient advocacy groups, and cancer associations to bridge the gap on the differing views of “value”.

Pre-Order the 2017 event brochure

Complete speaker line-up - Program for all tracks & sessions – Audience breakdown

Co-chaired by Aetna’s Michael Kolodziej, the 2016 conference was seen as the most targeted and high-level gathering on commercialization of cancer products in the US.

150+ senior executives attended, including the following leading oncology innovators:



  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee
  • Attendee

Why attend?

  • Value-Based Pricing Metrics Round Robin - Hear why payers are hungry for these models, how they may leverage them, and which metrics will make a significant impact on the market access environment
  • Determine How to Best Position Your Brand in an Evolving Market - Work cross-functionally with teams to address the challenges these metrics bring to develop a stronger market access trajectory by better demonstrating your products’ importance.
  • Prepare for Stakeholder’s Demands - Adopt new business strategies that effectively generate, manage, and apply relevant health economic and clinical data from drug development through reimbursement
  • Set Your Brand Apart in the Changing Payment Model Landscape - Decipher how potential APMs may impact your products and determine which are likely to have significant risks for the adoption of innovative drugs and biologics

Our 2016 Speaker Line-Up

William Hinshaw
William Hinshaw

Novartis

Executive VP, US Oncology

Michael Ryan
Michael Ryan

Bristol-Myers Squibb

SVP US Value, Access, & Policy

Anil Kapur
Anil Kapur

Baxalta

VP & Global Head of Oncology Commercial

Anna Forsythe
Anna Forsythe

Eisai

Senior Director & Head of Global Value & Access

Richard Schilsky
Richard Schilsky

ASCO

CMO

Michael Kolodziej
Michael Kolodziej

Aetna

National Medical Director

Our Track-Record of Proven Success

83%

call our sessions essential

94%

said they will likely return again next year

97%

rated the program very well run

What our Delegates are saying